BIOMAT Database Logo BIOMAT Database Logo

[Streptokinase therapy of fresh myocardial infarct. Results of a double blind study]. 1972

H J Krzywanek, and K Breddin

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D013300 Streptokinase Streptococcal fibrinolysin . An enzyme produced by hemolytic streptococci. It hydrolyzes amide linkages and serves as an activator of plasminogen. It is used in thrombolytic therapy and is used also in mixtures with streptodornase (STREPTODORNASE AND STREPTOKINASE). EC 3.4.-. Avelizin,Awelysin,Celiase,Distreptase,Kabikinase,Kabivitrum,Streptase,Streptodecase

Related Publications

H J Krzywanek, and K Breddin
[Streptokinase therapy of myocardial infarct].
January 1971, Medizinische Monatsschrift,
H J Krzywanek, and K Breddin
[Systemic streptokinase therapy of myocardial infarct].
April 1983, Orvosi hetilap,
H J Krzywanek, and K Breddin
[Long-term results following therapy with streptokinase in myocardial infarct].
February 1986, Herz,
H J Krzywanek, and K Breddin
[The therapy of myocardial infarct with streptokinase].
December 1965, Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,
H J Krzywanek, and K Breddin
[Therapy of acute myocardial infarct using streptokinase].
May 1973, Medizinische Klinik,
H J Krzywanek, and K Breddin
[THROMBOLYTIC THERAPY OF MYOCARDIAL INFARCT WITH STREPTOKINASE].
January 1965, Das Deutsche Gesundheitswesen,
H J Krzywanek, and K Breddin
[Therapy of the fresh myocardial infarct].
April 1957, Munchener medizinische Wochenschrift (1950),
H J Krzywanek, and K Breddin
Buccally administered streptokinase: a double blind study.
June 1966, Australian dental journal,
H J Krzywanek, and K Breddin
[Experience with streptokinase therapy of acute myocardial infarct].
October 1982, Orvosi hetilap,
H J Krzywanek, and K Breddin
[Thrombolytic therapy in fresh myocardial infarct].
November 1987, Wiener medizinische Wochenschrift (1946),
Copied contents to your clipboard!